Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 16, 1998

View Archived Issues

Inspire enters into strategic partnership with Kissei

Pylorid-containing triple therapy effective in eradicating H. pylori

Matrix completes enrollment in IntraDose trials

Corixa's MUC-1 vaccine technology receives patent protection

Wafer formulation of rizatriptan delivers fast and effective migraine relief

Positive clinical data from temozolomide trials presented at European oncology meeting

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Anthraquinone telomerase inhibitors developed at CRC Technology

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Organon designs novel acylguanidine-containing thrombin inhibitors

Joint venture for development of MPS I treatment now a reality

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Algos releases phase III clinical trial results for MorphiDex

Committee recommends approval of test to identify candidates for treatment with Herceptin

European-wide approval for Viagra

RPR will introduce CombiPatch in U.S. during third quarter

Novel treatment for breast cancer available for licensing

BioCryst licenses small-molecule neuraminidase inhibitors to J&J companies

FDA clears diagnostic for DVT - a potentially life-threatening disorder

YM-75466 exerts antithrombotic effects at doses that do not alter bleeding and coagulation times

European marketing application for Myotrophin withdrawn

Bioniche receives EU registration for Cystistat

Biovail subsidiary will market clot buster in Canada

Cytogen's Cellcor subsidiary closes operations this week

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...